Skip to content

Koniku

A California biotechnology and technology company developing hybrid biological-neural and silicon sensing systems.

Last updated October 14, 2026

AI crawler reads

No AI crawler has read this profile since Oct 28, 2026.

Overview

Koniku is a California-based biotechnology and technology company focused on hybrid computing and sensing systems that combine living biological neurons with silicon electronics. The company’s work is generally associated with wetware devices, machine olfaction, biosensing, and the use of engineered biological receptors to identify chemical signatures in real time. Its name is derived from a Yoruba word meaning “immortal.” The company was founded in 2015 by Osh Agabi, although the underlying research concept predates Koniku. Agabi’s interest in biological computing developed during work at ETH Zurich, where he was involved with the IMPLO project and research into chips influenced by biological information processing. He later continued related work at Imperial College London, exploring the possibility of using living neurons as components in computing and sensing systems. After obtaining funding in 2016, Agabi established Koniku in Silicon Valley. Koniku initially described its development path as a progression from biological sensing to biological control systems and eventually to cognition-oriented systems. Rather than attempting to reproduce the entire human brain, the company concentrated on practical interfaces between biological components and digital hardware. Its best-known product is Konikore, a hybrid electronic-olfaction system sometimes described publicly as a “smell cyborg.” Konikore uses engineered biological cells or neurons equipped with olfactory receptors to recognize target compounds. Electrical activity generated by the biological component is read through a silicon-based interface and processed digitally. The technology was publicly presented by Agabi at TEDGlobal in 2017 and later developed as a business-to-business sensing platform. Koniku has described potential uses across aviation security, explosives and chemical detection, healthcare diagnostics, food authentication, flavor analysis, agriculture, and industrial monitoring. The system’s proposed advantage is that biological receptors can respond to complex odor signatures that may be difficult to reproduce with conventional electronic sensor arrays. The company has stated that its long-term objective is to digitize real-world smell information and make it available through a broader technology ecosystem. A major strand of Koniku’s work has involved aviation and security. The company began collaborating with Airbus in 2017 on systems intended to detect chemical, explosive, and biological threats in aviation environments. During the COVID-19 pandemic, the scope of this work was described as extending to biological hazard detection. In 2022, Airbus Americas was reported to have joined Koniku’s Technology Integrator Ecosystem, supporting work around a Konikore by Airbus system. The company has also discussed deployments or testing at San Francisco International Airport and in Gulf-region locations, although the available reference material does not establish the full commercial status or scale of those deployments. Koniku also pursued health-related applications during the pandemic. In collaboration with Treximo and the University of Southern Nevada, it conducted clinical testing of its sensing approach for possible rapid virus detection and sought a pathway toward emergency authorization. The reference material does not establish that the product received such authorization. Other proposed applications included detecting disease-related volatile compounds and using domestic environments as sources of continuous health-related odor data. In industrial and consumer applications, Koniku has discussed the detection of compounds such as benzene and xylene, food and beverage authentication, and flavor analysis. A 2021 relationship with Anheuser-Busch InBev was associated with beverage-related sensing and analysis. Koniku has also attracted investment, including investment reported to involve SoftBank. In 2025, the company became a founding member of Oracle’s Defense Ecosystem, linking its work to a wider cloud and defense technology initiative. Koniku’s approach remains technically ambitious. Specialists have pointed out that connecting living cells, natural protein receptors, and silicon circuitry is difficult because biological systems are complex, variable, and challenging to engineer reliably. The company therefore occupies an unusual position between biotechnology, semiconductor-adjacent hardware, artificial intelligence, and defense technology. Its public identity is built less around a conventional consumer brand than around the promise of practical biological sensing for security, industry, and healthcare.

History

Koniku was founded in 2015 by Osh Agabi in California. Its origins lie in earlier research into biological information processing and neuron-based computing. While working at ETH Zurich with Professor Henry Baltes on the IMPLO project in 2003, Agabi became involved with research related to chips influenced by biological systems. He later pursued related ideas at Imperial College London, where he focused on using living neurons and biological mechanisms in computing architectures. After securing funding in 2016, Agabi established Koniku in Silicon Valley. The company adopted a staged roadmap moving from biological sensing to biological control and, ultimately, cognition-oriented systems. Its practical entry point was sensing rather than general-purpose biological computing. Koniku sought to connect engineered cells containing olfactory receptors to silicon hardware so that biological responses to molecules could be converted into electronic signals. Koniku’s flagship platform, Konikore, became publicly associated with the company after Agabi presented it at TEDGlobal in 2017. The device was described as a “smell cyborg” because it combined living biological components with conventional electronics. Its intended function was to identify complex chemical signatures and odors, including substances relevant to explosives, biological threats, food, and industrial chemicals. Konikore was subsequently developed as a business-to-business product rather than a consumer electronics device. In 2017, Koniku began working with Airbus on aviation security applications. The collaboration was intended to support detection of chemical and explosive threats in aircraft and airport environments. During the COVID-19 pandemic, the reported scope expanded to include biological hazard detection. Koniku also pursued healthcare applications, including clinical testing with Treximo and the University of Southern Nevada for possible rapid virus detection. The reference material does not confirm that the system obtained emergency authorization or became a broadly approved diagnostic product. By 2020, Koniku was presenting its platform as a general-purpose chemical and odor-sensing system with applications in food authentication, flavor analysis, agriculture, disease detection, and industrial monitoring. The company stated that the system could identify more than 4,000 compounds and proposed a long-term goal of digitizing smell data through the Koniku Technology Integrator Ecosystem. It also discussed using odor data from everyday spaces as a potential source of health information. Koniku continued to develop commercial and ecosystem relationships. In 2021, it was associated with Anheuser-Busch InBev for beverage and flavor-related applications. In 2022, Airbus Americas joined the Technology Integrator Ecosystem, with the relationship connected to work on the Konikore by Airbus system. The technology was reported in connection with San Francisco International Airport and locations in the Gulf States, although the available source does not provide enough detail to determine the scale, duration, or formal procurement status of those activities. The company has also received investment, including investment reported to involve SoftBank. In 2025, it became a founding member of Oracle’s Defense Ecosystem, extending its profile into a broader cloud-enabled defense technology network. Koniku’s technology has attracted both interest and skepticism. Its proposed architecture requires biological receptors and living cells to operate as reliable components of an engineered electronic system. Critics have emphasized the difficulty of controlling biological variability and integrating natural protein receptors with silicon circuits. These technical constraints are central to Koniku’s identity: the company’s proposition is distinctive precisely because it attempts to use biology as a functional sensing layer rather than merely as inspiration for conventional software or electronics.

  • 2025

    Founding membership in Oracle Defense Ecosystem

    [1]

    Koniku became a founding member of Oracle’s Defense Ecosystem.

  • 2022

    Airbus Americas joins the technology ecosystem

    [1]

    Airbus Americas joined Koniku’s Technology Integrator Ecosystem in connection with development of the Konikore by Airbus system.

  • 2021

    Beverage and flavor-analysis collaboration

    [1]

    Koniku was associated with Anheuser-Busch InBev in work involving the use of biological sensing for beverage and flavor analysis.

  • 2020

    Pandemic-era virus detection testing

    [1]

    Koniku conducted clinical testing with Treximo and the University of Southern Nevada to evaluate whether its sensing approach could support rapid virus detection.

  • 2018

    Konikore becomes a business-to-business product

    [1]

    Koniku introduced Konikore as a business-to-business sensing product based on engineered biological neurons and silicon electronics.

  • 2017

    Konikore is publicly presented

    [1]

    Konikore was presented at TEDGlobal as a hybrid biological-electronic device for real-time odor and chemical detection.

  • 2017

    Airbus collaboration begins

    [1]

    Koniku began a collaboration with Airbus on aviation security systems intended to identify chemical and explosive threats.

  • 2016

    Silicon Valley establishment

    [1]

    After obtaining funding, Koniku established its operations in Silicon Valley and pursued a staged roadmap from biological sensing toward more advanced biological computing.

  • 2015

    Koniku is founded

    [1]

    Osh Agabi founded Koniku to develop computing and sensing systems that combine biological components with silicon hardware.

  • 2003

    Early biological-computing research

    [1]

    While working at ETH Zurich on the IMPLO project, Osh Agabi developed research interests that later informed Koniku’s neuron-based computing and sensing concepts.

Products and positioning

Koniku positions itself at the intersection of biotechnology, wetware computing, machine olfaction, and advanced security sensing. Its differentiation is the use of living biological receptors and neurons as front-end sensing elements connected to silicon electronics and digital processing.

  • Hybrid electronic olfaction and biosensing system · 2017

    Konikore

    Konikore is Koniku’s best-known platform. It combines engineered biological cells or neurons carrying olfactory receptors with silicon-based electronics. The biological component is intended to bind to selected chemical targets and produce a measurable response, while the electronic interface reads and digitally processes that response. Proposed uses include explosive and chemical threat detection, food authentication, flavor analysis, agriculture, disease-related odor detection, and industrial monitoring.

  • Aviation security sensing system · 2022

    Konikore by Airbus

    Konikore by Airbus refers to the aviation-focused development and integration of Koniku’s sensing platform with Airbus. The system was intended to support detection of chemical, explosive, and biological hazards in aircraft and airport environments. Public reference material connects the effort with testing or deployment discussions involving San Francisco International Airport and Gulf-region locations, but does not establish comprehensive commercial deployment details.

  • Technology integration and data ecosystem

    Koniku Technology Integrator Ecosystem

    The Koniku Technology Integrator Ecosystem is a proposed platform for connecting Koniku’s biological sensing technology with partners, applications, and data-processing systems. Its stated long-term role is to support the digitization and broader use of smell and chemical-signature data across security, healthcare, industrial, agricultural, and consumer applications.

Marketing campaigns

  • 2020COVID-19 detection development program

    United States

    During the COVID-19 pandemic, Koniku worked with Treximo and the University of Southern Nevada on clinical testing of its sensing platform for rapid virus detection.

    Outcome. Testing was reported, but the available material does not confirm emergency authorization or broad clinical commercialization.

  • 2017TEDGlobal Konikore presentation

    International technology and innovation audience

    Osh Agabi introduced Konikore as a biological-electronic “smell cyborg,” using a high-profile technology conference to explain Koniku’s approach to machine olfaction and wetware sensing.

    Outcome. The presentation established Konikore as the company’s signature public concept and increased visibility for Koniku’s biological-sensing agenda.

Brand decisions

  • 2025

    Join Oracle’s Defense EcosystemStrategy

    Background

    Koniku’s threat-detection and biological-sensing work has relevance to defense and security environments that require cloud-connected technical systems.

    Action taken

    Koniku became a founding member of the Oracle Defense Ecosystem.

    Aftermath

    The membership connected Koniku with Oracle’s broader defense technology and cloud ecosystem, although the available source does not specify resulting contracts or deployments.

  • 2022

    Develop a partner ecosystem around KonikoreStrategy

    Background

    Scaling specialized biological sensors requires integration with aviation, cloud, data, and application partners.

    Action taken

    Koniku expanded its Technology Integrator Ecosystem, with Airbus Americas reported as a participant in work connected to Konikore by Airbus.

    Aftermath

    The company emphasized collaborative deployment and integration rather than presenting Konikore solely as a standalone hardware device.

  • 2020

    Broaden Konikore beyond securityStrategy

    Background

    Koniku’s biological sensing architecture could potentially identify chemical patterns relevant to healthcare, food, agriculture, and industrial monitoring in addition to airport security.

    Action taken

    The company presented Konikore as a multipurpose platform and described applications ranging from food authentication and flavor analysis to disease detection and monitoring of industrial compounds.

    Aftermath

    Koniku’s positioning expanded from aviation threat detection toward a wider machine-olfaction and chemical-data ecosystem.

  • 2017

    Enter aviation security through the Airbus collaborationOther

    Background

    Airports and aircraft require systems capable of identifying chemical and explosive threats, creating a potential security application for biological odor sensing.

    Action taken

    Koniku began working with Airbus on biological threat-detection systems for aviation. The reported contract was valued at approximately $8 million.

    Aftermath

    The Airbus relationship became one of Koniku’s principal routes into aviation and defense-related applications.

    Reported contract value. $8 million (2017)

  • 2016

    Adopt a staged biological-computing roadmapStrategy

    Background

    Koniku’s founding vision involved using biological neurons and related mechanisms in computing. The company needed an initial application that could be developed before attempting broader biological control or cognition systems.

    Action taken

    The company prioritized biological sensing as its first practical stage, with longer-term ambitions involving control systems and cognition-oriented technologies.

    Aftermath

    Konikore became the central product and the company’s public work concentrated on machine olfaction and chemical detection.

Sources1 sources

Cite this profile: Cite the canonical profile. /brand-wiki/koniku · Editorial policy · How profiles are compiled